In-vitro Colorectal Cancer Screening Tests Market Share 2027

IMARC Group’s latest research report, titled “In-vitro Colorectal Cancer Screening Tests Market: Global Industry Trends, Share, Size, Growth, Opportunity, and Forecast 2022-2027,” offers a comprehensive analysis of the industry, which comprises insights on the global In-vitro colorectal cancer screening tests market size. The report also includes competitor and regional analysis, and contemporary advancements in the market.

The global in-vitro colorectal cancer screening tests market reached a value of US$ 880.1 Million in 2021. Looking forward, IMARC Group expects the market to reach a value of US$ 1,284.90 Million by 2027, exhibiting a CAGR of 6.10% during 2022-2027. In-vitro colorectal cancer screening tests are used to detect the presence of colorectal cancer. Colorectal cancer is of two types, namely bowel and colon cancer, which starts with a foreign growth on the inner lining of the colon or rectum. It includes a fecal occult blood test, biomarker tests, and CRC DNA screening tests. These tests are performed across hospitals, clinics, diagnostics laboratories, and ambulatory surgical centers.

Get Free Sample Copy of Report at – https://www.imarcgroup.com/in-vitro-colorectal-cancer-screening-tests-market/requestsample

Important Attribute and highlights of the Report:

Detailed analysis of the global market share
Market Segmentation by product, imaging type and end user.
Historical, current, and projected size of the market in terms of volume and value
Latest industry trends and developments
Competitive Landscape for In-vitro Colorectal Cancer Screening Tests Market
Strategies of major players and product offerings

The global market is primarily driven by the rising prevalence of colorectal cancer. In line with this, the augmenting utilization of in-vitro colorectal cancer screening tests for diagnosing recurrence after therapy and surgery is favorably influencing the market. Furthermore, the growing awareness among the masses regarding the high-accuracy rates of in-vitro colorectal cancer screening tests is creating a positive outlook for the market. Additionally, continual technological advancements for cancer screening and the rapid expansion of screening activities are providing a boost to market growth across the globe.

Key Players Included in Global In-vitro Colorectal Cancer Screening Tests Market Research Report:

Beckman Coulter Inc. (Danaher Corporation)
Eiken Chemical Co. Ltd.
Epigenomics AG
Exact Sciences Corporation
Hemosure Inc.
Immunostics Inc. (Boditech Med Inc.)
Medline Industries LP
Merck KGaA, Qiagen N.V.
Quest Diagnostics Incorporated
R-Biopharm AG
Siemens AG and Sysmex Corporation

COVID-19 Impact Overview:

We are regularly tracking the direct effect of COVID-19 on the market, along with the indirect influence of associated industries. These observations will be integrated into the report

Key Market Segmentation:

Breakup by Product:

Fecal Occult Blood Tests

Guaiac FOB Stool Test
Immuno-FOB Agglutination Test
Lateral Flow Immuno-FOB Test
Immuno-FOB ELISA Test

Biomarker Tests

Tumor M2-PK Stool Test
Transferrin Assays

CRC DNA Screening Tests

Methylated Gene Testing
Panel DNA Tests

Breakup by Imaging Type:

Colonoscopy
Proctoscopy
CT Scan
Ultrasound
MRI
PET Scan

Breakup by End User:

Hospitals
Clinics
Diagnostic Laboratories
Others

Breakup by Region:

North America (United States, Canada)
Asia Pacific (China, Japan, India, Australia, Indonesia, Korea, Others)
Europe (Germany, France, United Kingdom, Italy, Spain, Others)
Latin America (Brazil, Mexico, Others)
Middle East and Africa (United Arab Emirates, Saudi Arabia, Qatar, Iraq, Other)

TOC for the In-vitro Colorectal Cancer Screening Tests Market Research Report:

Preface
Scope and Methodology
Executive Summary
Introduction
Global In-vitro Colorectal Cancer Screening Tests Market
SWOT Analysis
Value Chain Analysis
Price Analysis
Competitive Landscape

Who we are:

IMARC Group is a leading market research company that offers management strategy and market research worldwide. We partner with clients in all sectors and regions to identify their highest-value opportunities, address their most critical challenges, and transform their businesses.

IMARC’s information products include major market, scientific, economic and technological developments for business leaders in pharmaceutical, industrial, and high technology organizations. Market forecasts and industry analysis for biotechnology, advanced materials, pharmaceuticals, food and beverage, travel and tourism, nanotechnology and novel processing methods are at the top of the company’s expertise.